The global market for brain metastasis treatment is poised for remarkable growth, projected to surge from approximately USD 4,282.22 million in 2025 to USD 8,823.13 million by 2035. This robust ...

NASAL tanning sprays may increase the risk of melanoma skin cancer, it’s been warned. The sprays – often sold on social media ...

At just 22, Kaylee Engle dismissed the first strange lump near her breast-but when new ones appeared daily, she feared the ...

A doctor has warned the public to pay attention to any change to their skin after he was dealt a shock diagnosis of deadly ...

Learn the ABCDEs of skin cancer for early detection and prevention. Recognize signs, act fast, and stay informed this May ...

First Patient Enrolled in Multi-Dose Phase 1b/2 Trial of Bel-sar in Non-Muscle-Invasive Bladder Cancer (NMIBC); Initial Data at 3 Months Expected by Year-End 2025 Strengthened Leadership Team with the ...

With pricing reforms and PBM overhauls looming, pharma investors need to differentiate between companies that can absorb ...

Cancer care has changed dramatically over the last decade. As opposed to a "one-size-fits-all" approach, treatment today is ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

Analysts are estimating that Exelixis will report an earnings per share (EPS) of $0.38. The announcement from Exelixis is ...

Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...

IOVA reports $49.3M revenue, Replimune's RP1 approval set for July, and Obsidian's OBX-115 trial data unveils at ASCO in June ...